Cargando…
Quercetin Inhibits Lef1 and Resensitizes Docetaxel-Resistant Breast Cancer Cells
Drug resistance is a major problem for breast cancer patients. Docetaxel is an anti-mitotic agent that serves as first line of treatment in metastatic breast cancer, however it is susceptible to cellular drug resistance. Drug-resistant cells are able to spread during treatment, leading to treatment...
Autores principales: | Prieto-Vila, Marta, Shimomura, Iwao, Kogure, Akiko, Usuba, Wataru, Takahashi, Ryou-u, Ochiya, Takahiro, Yamamoto, Yusuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321307/ https://www.ncbi.nlm.nih.gov/pubmed/32492961 http://dx.doi.org/10.3390/molecules25112576 |
Ejemplares similares
-
Drug Resistance Driven by Cancer Stem Cells and Their Niche
por: Prieto-Vila, Marta, et al.
Publicado: (2017) -
Exploiting the message from cancer: the diagnostic value of extracellular vesicles for clinical applications
por: Kosaka, Nobuyoshi, et al.
Publicado: (2019) -
Cancer extracellular vesicles contribute to stromal heterogeneity by inducing chemokines in cancer-associated fibroblasts
por: Naito, Yutaka, et al.
Publicado: (2019) -
Development of miRNA‐based therapeutic approaches for cancer patients
por: Takahashi, Ryou‐u, et al.
Publicado: (2019) -
Synthetic Lethality in Lung Cancer—From the Perspective of Cancer Genomics
por: Shimomura, Iwao, et al.
Publicado: (2019)